Publication | Closed Access

Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients

Tamoxifen-induced Uterine ChangesBreast OncologyHormonal ContraceptiveThird GenerationMedicineEndometrial GrowthGynecologyAromataseMenopauseBreast CancerEndocrinologyPharmacologyOvarian HormoneEndocrine-related CancerWomen's Health